Guia Covid-19

Public health

COVID-19

Antibody treatment reduces time spent in hospital

American pharmaceutical company Eli Lilly presented the initial results of a clinical trial that used monoclonal antibodies in patients infected with the novel coronavirus

By

COVID-19

Obesity can exacerbate COVID-19

A large-scale study found that obese people infected with SARS-CoV-2 are twice as likely to need medical care

By

Video

Why the Covid-19 vaccine is important

Never before so many vaccines have been developed at the same time against a single disease, nor so rapidly | 7'32

By

Cover

The distance between dental research and treatment

The pandemic focuses attention on the debate regarding scientific production and dental care in the public healthcare system

By

Cover

The uncertainty of herd immunity

With a lack of scientific consensus on the subject, experts warn that protection measures against COVID-19 must be maintained

By

Cover

Potential treatment

With no effective antiviral therapy, COVID-19 management for the time being consists of reducing inflammation and preventing blood clots

By

Cover

The effects of COVID-19

The novel coronavirus can affect the lungs, heart, kidneys, pancreas, and brain, causing long-term damage after the acute phase of the disease has passed

By

COVID-19

The content of fake news

Scientific institutions have created websites to combat fake news

By

COVID-19

Intranasal coronavirus vaccine

Two international studies have suggested that COVID-19 aerosol vaccine candidates, administered intranasally, offer protection against SARS-CoV-2 infection in animals

By

COVID-19

High levels of asymptomatic infection in children

Clinical data suggest that although children and young adults tend to develop milder symptoms of COVID-19, they can be silent spreaders of the disease

By

Health

Low vitamin D levels

In Brazil, about 875,000 people aged over 50 are deficient in vitamin D

By

Retrospect

War on the plague

Doctors and public authorities acted quickly against a bubonic plague outbreak in Santos in 1899

By

Public Policy

Opening faucets

Lack of basic sanitation in Brazil damages public health and the economy

By

Cover

The risk of traveling by plane

The probability of catching a respiratory virus, such as the novel coronavirus, is high for those close to a contaminated passenger and low for those further away

By

Cover

The puzzle of immunity

Crucial questions about the response of the immune system to the novel coronavirus remain unanswered

By

Cover

Health professionals under emotional stress

Depression rates for health professionals who care for COVID-19 patients have tripled

By

Cover

The emotional pain of the pandemic

Psychological suffering and mental illness caused by radical changes to daily life, fear of getting sick, and an economic crisis

By

COVID-19

Vaccine tests advance

One of the best-known COVID-19 vaccine candidates achieved good results in the first phase of clinical trials

By

Cover

A difficult return

Brazil seeks health and education parameters for planning the resumption of in-person classes in its school systems

By

Cover

The challenge of calculating R

Poor data makes the effective reproduction rate difficult to track and is hampering the pandemic response

By

Cover

Difficult exit

Quarantine relaxation strategies differ around the country

By and

Cover

Each nation’s effort

Brazil’s government unfreezes funding for COVID-19 research, but will spend far less than developed countries

By

Cover

Calling all scientists

Researchers in São Paulo mobilize against the pandemic as FAPESP awards funding to 210 related projects

By

INTERVIEW

Cristiana Toscano: An unprecedented global effort

According to the only Brazilian member of a WHO vaccine committee, we are experiencing unprecedented worldwide collaboration to develop a vaccine in record time

By

COVER

Standing alone

Brazilian vaccine projects race to begin clinical trials next year

By

COVER

Saving time

Brazilian research centers negotiate deals to import vaccine production technology

By

COVID-19

A SARS-CoV-2-proof fabric

Researchers from São Paulo–based company Nanox have developed a fabric containing silver nanoparticles that can inactivate the novel coronavirus, SARS-CoV-2

By

COVID-19

Platform gathers data on Brazilians with COVID-19

The COVID-19 Data Sharing/BR platform is a repository of clinical, laboratory and demographic data on people diagnosed with the infection in the country

By

Pandemic

3.1 million lives saved in Europe

The strict social distancing and lockdown measures implemented in 11 European countries before May 4 may have prevented 3.1 million COVID-19 deaths

By

Data

FAPESP funds COVID-19 research projects

Number of projects at each institution (as of 06/18/2020)

By